(Press-News.org) University researchers have carried out the largest systematic review and meta-analysis to date of how people's perceptions of their screen time compare with what they do in practice, finding estimates of usage were only accurate in about five per cent of studies.
The international team say this casts doubt on the validity of research on the impact of screen time on mental health, and its influences on government policy, as the vast majority rely on participants to estimate (self-report) how long they spend on digital devices, rather than logs of actual usage, or tracked time.
"For decades, researchers have relied on estimates of how we use various technologies to study how people use digital media and the potential outcomes this behaviour can lead to. Our findings suggest that much of this work may be on unstable footing," said lead researcher Dr Doug Parry at Stellenbosch University.
"The screen time discrepancies highlight that we simply do not know enough yet about the actual effects (both positive and negative) of our media use. Researchers, journalists, members of the public, and crucially policy makers need to question the quality of evidence when they consider research on media uses and effects. We can no longer simply take claims of harmful effects at face value."
The researchers also investigated whether questionnaires and scales addressing 'problematic' media use, such as excessive or so-called 'addictive' media use, were suitable substitutes for logged usage. They found an even smaller association with usage logs for these measures.
Published in Nature Human Behaviour, the research identified every existing study that compares logged or tracked media use measures with equivalent self-reports. They screened over 12,000 articles for inclusion and found 47 studies that included both types of measures. From here they were able to identify and extract 106 comparisons, based on 50,000 individuals, to address the question of how closely self-report estimates relate to logs of actual usage.
"These highly flawed studies are over-inflating the relationships between digital media use and typically negative outcomes, such as mental health symptoms and cognitive impairments, which of course explains the pervading view that smartphones among other technologies are bad for us," said Dr Brit Davidson from the University of Bath's School of Management.
"Media and technology use takes the blame for everything from increases in teenage depression and suicide to higher incidence of Attention Deficit Hyperactivity Disorder (ADHD) and violence. If we want to properly investigate harms, we must first tackle assumptions about screen time and disentangle how people are actually using their phones or other technologies of interest.
"Importantly, these questionable studies are also being used to influence policy. The UK and Canada both have forms of screen time guidelines based on poorly conducted research, which is clearly worrying and hard to reverse."
The research team also included Dr Craig Sewall at The University of Pittsburgh; Dr Jacob Fisher at the University of Illinois Urbana-Champaign; Hannah Mieczkowski at Stanford University; and Dr Daniel Quintana at the University of Oslo.
The researchers hope that their study will lead to a shift in measurement practices regarding technology, alongside starting to correct the narrative regarding technology and society. They say that only by better understanding what people actually do with their technologies, can we start to genuinely understand the impact of them on people and society.
A systematic review and meta-analysis of discrepancies between logged and self-reported digital media use is published by Nature Human Behaviour:
INFORMATION:
The pre-print paper is available from the press office, details below
The published paper will be available at: https://dx.doi.org/10.1038/s41562-021-01117-5
To contact the press office please email Alison Jones at a.jones4@bath.ac.uk or call 07966 341322.
University of Bath
The University of Bath is one of the UK's leading universities both in terms of research and our reputation for excellence in teaching, learning and graduate prospects. The University is rated Gold in the Teaching Excellence Framework (TEF), the Government's assessment of teaching quality in universities, meaning its teaching is of the highest quality in the UK. In the Research Excellence Framework (REF) 2014 research assessment 87 per cent of our research was defined as 'world-leading' or 'internationally excellent'.
From developing fuel efficient cars of the future, to identifying infectious diseases more quickly, or working to improve the lives of female farmers in West Africa, research from Bath is making a difference around the world.
Find out more: http://www.bath.ac.uk/research/. Well established as a nurturing environment for enterprising minds, Bath is ranked highly in all national league tables. We are ranked 6th in the UK by The Guardian University Guide 2021, and 9th in both The Times & Sunday Times Good University Guide 2021 and the Complete University Guide 2021. Our sports offering was rated as being in the world's top 10 in the QS World University Rankings by Subject in 2021.
A new study led by researchers from the Oxford University Museum of Natural History, University of Oxford and the University of Birmingham for Current Biology has used new methods to analyse the variability of mammal fossils, revealing extraordinary results: it was not dinosaurs, but possibly other mammals, that were the main competitors of modern mammals before and after the mass extinction of dinosaurs.
The study challenges old assumptions about why mammals only seemed to diversify, becoming larger and exploring new diets, locomotion and ways of life, after the extinction of the non-bird dinosaurs. It points to a more complex story of competition between distinct mammal groups. ...
Before undergoing surgery, patients often go through a number of tests: blood work, sometimes a chest X-ray, perhaps tests to measure heart and lung function.
In fact, about half of patients who had one of three common surgical procedures done in Michigan between 2015 and the midway point of 2019 received at least one routine test beforehand.
That's according to new research in JAMA Internal Medicine from a collaboration between the University of Michigan-based Michigan Program on Value Enhancement (MPrOVE) and the Michigan Value Collaborative, a statewide initiative that focuses on improving medical and surgical quality.
Yet plenty of evidence suggests that preoperative testing is often unnecessary ...
The experimental heart failure drug omecamtiv mecarbil reduced heart failure hospitalizations by a greater margin among patients with more severely reduced ejection fraction, a measure indicating severe impairment in the heart's pumping ability, compared with those who had moderately reduced ejection fraction, according to research presented at the American College of Cardiology's 70th Annual Scientific Session.
Omecamtiv mecarbil works by improving the ability for heart muscle cells to contract and operates through a different biological pathway than any of the current heart failure medications. The research ...
One of the enduring mysteries of the COVID-19 pandemic is why most children tend to experience fewer symptoms than adults after infection with the coronavirus. The immune system response that occurs in the rare cases in which children experience life-threatening reactions after infection may offer an important insight, a Yale-led study published in the journal Immunity suggests.
While many children infected with the virus are asymptomatic or go undiagnosed, about one in 1,000 children experience multi-system inflammatory response (MIS-C) four to six weeks after confirmed infection with SARS-CoV-2, the virus that causes COVID-19. The condition ...
Inserm teams led by Laurent Reber (Infinity, Toulouse) and Pierre Bruhns (Humoral Immunity, Institut Pasteur, Paris) and French company NEOVACS have developed a vaccine that could induce long-term protection against allergic asthma, reducing the severity of its symptoms and thus significantly improving patient quality of life. Their research in animals has been published in the journal Nature Communications.
Asthma is a chronic disease affecting around 4 million people in France and 340 million worldwide. Allergic asthma is characterized by inflammation of the bronchial tubes and respiratory discomfort caused by the inhalation of allergens, most often dust mites. This exposure to dust mites and other allergens leads to ...
A randomized double-blind controlled trial of convalescent plasma for adults hospitalized with severe COVID-19 found that mortality at 28 days in the treatment arm was half the rate seen in the control arm (12.6% vs. 24.6%), although treatment was not associated with other improvements in clinical status.
The study was led by investigators from the Center for Infection and Immunity at Columbia University Mailman School of Public Health; Columbia University Irving Medical Center; ICAP at Columbia University; Instituto Nacional de Infectologia and Hospital Federal dos Servidores do Estado in Rio de Janeiro, Brazil; University of Washington; and New York Blood Center. The results are published in the Journal of Clinical Investigation.
According ...
Patients with heart failure with preserved ejection fraction who took the antifibrotic drug pirfenidone saw a significant reduction in a marker of heart muscle scarring compared with patients who received a placebo, based on findings from an early-phase trial presented at the American College of Cardiology's 70th Annual Scientific Session.
"Observational data suggests that heart muscle scarring, or fibrosis, is an important disease process for heart failure prognosis," said Chris Miller, MD, a cardiologist and National Institute for Health Research Clinician Scientist at the University ...
Patients with heart failure with reduced ejection fraction (HFrEF) did not have better health outcomes if they took sacubitril/valsartan combination therapy compared with valsartan alone, according to new data presented at the American College of Cardiology's 70th Annual Scientific Session.
Heart failure, a leading cause of hospitalization among adults over age 65, is a condition in which the heart becomes too weak to pump blood effectively to the rest of the body, causing fatigue and shortness of breath. For patients with severe heart failure, treatment options are limited to a mechanical heart pump or heart transplant. Doctors have sought ways to slow the progression of severe heart failure ...
The likelihood of people surviving COVID-19 in UK hospitals has been improving over time, a new study has found.
Research published in The Lancet Respiratory Medicine by the ISARIC Coronavirus Clinical Characterisation Consortium found that in-hospital mortality declined from 32% at the start of the first wave (Mar-Apr 2020) to 16% at the end of the first wave (Jun-Jul 2020).
In their study of 63,972 adults admitted to 247 UK hospitals the researchers found reductions in mortality were observed in all age groups, in all ethnic groups, for both sexes, and in patients with and without comorbidities. This improvement was ...
A group of Brazilian and Portuguese researchers observed a correlation between the presence of lead in the organism and a microRNA (miRNA) that could be associated with the mechanisms that regulate DNA methylation, a physiological process required to control gene expression and ensure that genes function properly.
The alterations were detected in blood cells from workers in automotive battery plants, which use lead as a raw material. Curiously, lead levels in blood samples from 85 volunteers – averaging 20 micrograms per deciliter of blood (20 μg/dl) – were lower than the acceptable ceiling defined in Brazilian law (60 μg/dl).
The study was supported by FAPESP and ...
